Identification of Inequalities in the Selection of Liver Surgery for Colorectal Liver Metastases in Sweden

被引:39
作者
Noren, A. [1 ]
Sandstrom, P. [2 ,3 ]
Gunnarsdottir, K. [4 ]
Ardnor, B. [5 ]
Isaksson, B. [6 ]
Lindell, G. [7 ,8 ]
Rizell, M. [9 ]
机构
[1] Uppsala Univ, Dept Surg Sci, S-75183 Uppsala, Sweden
[2] Linkoping Univ, Dept Surg, Linkoping, Sweden
[3] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden
[4] Sahlgrens Univ Hosp, Reg Canc Ctr, Gothenburg, Sweden
[5] Umea Univ Hosp, Dept Surg, Umea, Sweden
[6] Uppsala Univ, Akad Hosp, Dept Surg Sci, Uppsala, Sweden
[7] Lund Univ, Skane Univ Hosp, Dept Surg, Lund, Sweden
[8] Lund Univ, Dept Clin Sci Lund, Lund, Sweden
[9] Sahlgrens Univ Hosp, Transplant Inst, Gothenburg, Sweden
关键词
Liver surgery; colorectal liver metastases; inequalities; selection factors; population-based; HEPATIC RESECTION; CHEMOTHERAPY; MANAGEMENT; SURVIVAL; CANCER; RESECTABILITY; CETUXIMAB; OUTCOMES; 10-YEAR;
D O I
10.1177/1457496918766706
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Liver resection for colorectal liver metastases offers a 5-year survival rate of 25%-58%. This study aimed to analyze whether patients with colorectal liver metastases undergo resection to an equal extent and whether selection factors play a role in the selection process. Material and Methods: Data were retrieved from the Swedish Colorectal Cancer Registry (2007-2011) for colorectal cancer and colorectal liver metastases. The patients identified were linked to the Swedish Registry of Liver and Bile surgery and the National Patient Registry to identify whether liver surgery or ablative treatment was performed. Analyses for age, sex, type of primary tumor and treating hospital (university, county, or district), American Society of Anesthesiologists class, and radiology for detection of metastatic disease were performed. Results: Of 28,355 patients with colorectal cancer, 21.6% (6127/28,355) presented with liver metastases. Of the patients with liver metastases, 18.5% (1134/6127) underwent liver resection or ablation. The cumulative proportion of liver resection/ablation was 4% (1134/28,355) of all colorectal cancer. If "not bowel resected" were excluded, the proportion slightly increased to 4.7% (1134/24,262). Around 15% of the patients with metastases were registered as referrals for liver surgery. In a multivariable analysis patients treated at a university hospital for primary tumor were more frequently surgically treated for liver metastases (p < 0.0001). Patients with liver metastases from rectal cancer (p < 0.0001) and men more often underwent liver resection (p = 0.006). A difference was found between health-care regions for the frequency of liver surgery (p < 0.0001). Patients >70 years and those with American Society of Anesthesiologists class >2 underwent liver resection less frequently. Magnetic resonance imaging of the liver was more often used in diagnostic work-up in men. Conclusion: Patients with colorectal liver metastases are unequally treated in Sweden, as indicated by the low referral rate. The proximity to a hepatobiliary unit seems important to enhance the patient's chances of being offered liver surgery.
引用
收藏
页码:294 / 301
页数:8
相关论文
共 19 条
[1]   Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway [J].
Angelsen, J-H. ;
Horn, A. ;
Sorbye, H. ;
Eide, G. E. ;
Loes, I. M. ;
Viste, A. .
BRITISH JOURNAL OF SURGERY, 2017, 104 (05) :580-589
[2]  
[Anonymous], 2015, NATL REPORT SWEDISH
[3]   Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer [J].
Bokemeyer, Carsten ;
Bondarenko, Igor ;
Makhson, Anatoly ;
Hartmann, Joerg T. ;
Aparicio, Jorge ;
de Braud, Filippo ;
Donea, Serban ;
Ludwig, Heinz ;
Schuch, Gunter ;
Stroh, Christopher ;
Loos, Anja H. ;
Zubel, Angela ;
Koralewski, Piotr .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) :663-671
[4]   Surgical resection and pen-operative chemotherapy for colorectal cancer liver metastases: A population-based study [J].
Booth, C. M. ;
Nanji, S. ;
Wei, X. ;
Biagi, J. J. ;
Krzyzanowska, M. K. ;
Mackillop, W. J. .
EJSO, 2016, 42 (02) :281-287
[5]   Trends in long-term survival following liver resection for hepatic colorectal metastases [J].
Choti, MA ;
Sitzmann, JV ;
Tiburi, MF ;
Sumetchotimetha, W ;
Rangsin, R ;
Schulick, RD ;
Lillemoe, KD ;
Yeo, CJ ;
Cameron, JL .
ANNALS OF SURGERY, 2002, 235 (06) :759-765
[6]   Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma [J].
Hackl, Christina ;
Neumann, Peter ;
Gerken, Michael ;
Loss, Martin ;
Klinkhammer-Schalke, Monika ;
Schlitt, Hans J. .
BMC CANCER, 2014, 14
[7]   Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases [J].
Homayounfar, K. ;
Bleckmann, A. ;
Helms, H. -J. ;
Lordick, F. ;
Rueschoff, J. ;
Conradi, L. -C. ;
Sprenger, T. ;
Ghadimi, M. ;
Liersch, T. .
BRITISH JOURNAL OF SURGERY, 2014, 101 (05) :550-557
[8]   A GOODNESS-OF-FIT TEST FOR BINARY REGRESSION-MODELS, BASED ON SMOOTHING METHODS [J].
LECESSIE, S ;
VANHOUWELINGEN, JC .
BIOMETRICS, 1991, 47 (04) :1267-1282
[9]   A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer [J].
Leporrier, J ;
Maurel, J ;
Chiche, L ;
Bara, S ;
Segol, P ;
Launoy, G .
BRITISH JOURNAL OF SURGERY, 2006, 93 (04) :465-474
[10]   A 10-year study of outcome following hepatic resection for colorectal liver metastases - The effect of evaluation in a multidisciplinary team setting [J].
Lordan, J. T. ;
Karanjia, N. D. ;
Quiney, N. ;
Fawcett, W. J. ;
Worthington, T. R. .
EJSO, 2009, 35 (03) :302-306